Penumbra, Inc. (PEN)
320.50
-7.70
(-2.35%)
USD |
NYSE |
May 27, 16:00
320.01
-0.48
(-0.15%)
After-Hours: 18:43
Penumbra Cash from Investing (Quarterly) : -30.63M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -591.00M |
| Abbott Laboratories | -20.32B |
| Insulet Corp. | -27.70M |
| Globus Medical, Inc. | -182.67M |
| Intuitive Surgical, Inc. | -914.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 86.97M |
| Cash from Financing (Quarterly) | -1.907M |
| Free Cash Flow | 212.73M |
| Free Cash Flow Per Share (Quarterly) | 1.854 |
| Free Cash Flow to Equity (Quarterly) | 76.82M |
| Free Cash Flow to Firm (Quarterly) | 73.55M |
| Free Cash Flow Yield | 1.69% |